Here, based on current evidences, we performed a systematic review of the literature with a meta-analysis to determine the association between CSCs marker CD133 and the clinicopathological characteristics of gastric cancer and to investigate the roles of CD133 in the prognosis of gastric cancer. This evidence concerns the gene PROM1 and gastric cancer.